A Post-marketing Database Surveillance to Investigate the Risk of Hepatic Events in Hypercholesterolemic Patients Treated with ATOZET or Ezetimibe Atorvastatin coadministration in Japan (MK-0653C-853)

15/06/2021
23/04/2024
EU PAS number:
EUPAS41295
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

MK-0653C-853-00-v2-Prot_Final Redaction

English (1.46 MB - PDF) View document
Study results
Study results

MK0653C-853-CSR_final redaction

English (2.72 MB - PDF) View document
Study report
Other information